Anthera Pharma (ANTH) Misses Q1 EPS by 1c

Anthera Pharma (NASDAQ: ANTH) reported Q1 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• Trend Micro Incorporated (4704:JP) (TMICY) PT Lowered to JPY5,900 at Goldman Sachs
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance